• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单胺氧化酶A和B抑制剂的定量构效关系及复杂网络方法

Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.

作者信息

Santana Lourdes, González-Díaz Humberto, Quezada Elías, Uriarte Eugenio, Yáñez Matilde, Viña Dolores, Orallo Francisco

机构信息

Department of Organic Chemistry, Department of Pharmacology, Faculty of Pharmacy, University of Santiago de Compostela 15782, Spain.

出版信息

J Med Chem. 2008 Nov 13;51(21):6740-51. doi: 10.1021/jm800656v. Epub 2008 Oct 4.

DOI:10.1021/jm800656v
PMID:18834112
Abstract

The work provides a new model for the prediction of the MAO-A and -B inhibitor activity by the use of combined complex networks and QSAR methodologies. On the basis of the obtained model, we prepared and assayed 33 coumarin derivatives, and the theoretical prediction was compared with the experimental activity data. The model correctly predicted 27 compounds, and most of the active derivatives showed IC 50 values in the muM-nM range against both the MAO-A and MAO-B isoforms. Compound 14 shows the same MAO-A inhibitory activity (IC 50 = 7.2 nM), as clorgyline used as a reference inhibitor and has the highest MAO-A specificity (1000-fold higher compared to MAO-B). On the other hand, compounds 24 (IC 50 = 1.2 nM) and 28 (IC 50 = 1.5 nM) show higher activity than selegiline (IC 50 = 19.6 nM) and high MAO-B selectivity with 100-fold and 1600-fold inhibition levels, with respect to the MAO-A isoform.

摘要

该研究通过联合使用复杂网络和定量构效关系(QSAR)方法,为预测单胺氧化酶A(MAO-A)和单胺氧化酶B(MAO-B)抑制剂活性提供了一种新模型。基于所获得的模型,我们制备并测定了33种香豆素衍生物,并将理论预测结果与实验活性数据进行了比较。该模型正确预测了27种化合物,大多数活性衍生物对MAO-A和MAO-B亚型的半数抑制浓度(IC50)值在微摩尔至纳摩尔范围内。化合物14表现出与用作参考抑制剂的氯吉兰相同的MAO-A抑制活性(IC50 = 7.2 nM),并且具有最高的MAO-A特异性(与MAO-B相比高1000倍)。另一方面,化合物24(IC50 = 1.2 nM)和化合物28(IC50 = 1.5 nM)表现出比司来吉兰(IC50 = 19.6 nM)更高的活性,并且相对于MAO-A亚型,对MAO-B具有100倍和1600倍的抑制水平,具有高MAO-B选择性。

相似文献

1
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.单胺氧化酶A和B抑制剂的定量构效关系及复杂网络方法
J Med Chem. 2008 Nov 13;51(21):6740-51. doi: 10.1021/jm800656v. Epub 2008 Oct 4.
2
Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.一些新型六氢吲唑衍生物作为强效单胺氧化酶抑制剂的合成与分子模拟
Bioorg Med Chem. 2009 Sep 15;17(18):6761-72. doi: 10.1016/j.bmc.2009.07.033. Epub 2009 Jul 23.
3
Sulfur-substituted alpha-alkyl phenethylamines as selective and reversible MAO-A inhibitors: biological activities, CoMFA analysis, and active site modeling.硫取代的α-烷基苯乙胺作为选择性和可逆的单胺氧化酶-A抑制剂:生物活性、比较分子力场分析及活性位点建模
J Med Chem. 2005 Apr 7;48(7):2407-19. doi: 10.1021/jm0493109.
4
Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors.6-甲基-3-苯基香豆素作为强效和选择性单胺氧化酶-B抑制剂的合成与评价
Bioorg Med Chem Lett. 2009 Sep 1;19(17):5053-5. doi: 10.1016/j.bmcl.2009.07.039. Epub 2009 Jul 10.
5
A QSAR model for in silico screening of MAO-A inhibitors. Prediction, synthesis, and biological assay of novel coumarins.一种用于在计算机上筛选单胺氧化酶-A抑制剂的定量构效关系模型。新型香豆素的预测、合成及生物学测定。
J Med Chem. 2006 Feb 9;49(3):1149-56. doi: 10.1021/jm0509849.
6
Inhibition of monoamine oxidase by 8-benzyloxycaffeine analogues.8-苄氧基咖啡因类似物对单胺氧化酶的抑制作用。
Bioorg Med Chem. 2010 Feb;18(3):1018-28. doi: 10.1016/j.bmc.2009.12.064. Epub 2010 Jan 6.
7
Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor.一类新型强效香豆素单胺氧化酶B抑制剂的发现:7-[(3-氯苄基)氧基]-4-[(甲氨基)甲基]-2H-色烯-2-酮甲磺酸盐(NW-1772)作为一种高效、选择性、可逆且口服活性的单胺氧化酶B抑制剂的研发及生物药理学分析
J Med Chem. 2009 Nov 12;52(21):6685-706. doi: 10.1021/jm9010127.
8
Synthesis, molecular modeling studies and selective inhibitory activity against MAO of N1-propanoyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives.N1-丙酰基-3,5-二苯基-4,5-二氢-(1H)-吡唑衍生物的合成、分子建模研究及其对单胺氧化酶的选择性抑制活性
Eur J Med Chem. 2008 Oct;43(10):2262-7. doi: 10.1016/j.ejmech.2007.12.026. Epub 2008 Jan 6.
9
Synthesis and selective inhibitory activity of 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives against monoamine oxidase.1-乙酰基-3,5-二苯基-4,5-二氢-(1H)-吡唑衍生物对单胺氧化酶的合成及选择性抑制活性
J Med Chem. 2004 Apr 8;47(8):2071-4. doi: 10.1021/jm031042b.
10
MAO inhibitory activity modulation: 3-Phenylcoumarins versus 3-benzoylcoumarins.MAO 抑制活性调节:3-苯基香豆素与 3-苯甲酰基香豆素。
Bioorg Med Chem Lett. 2011 Jul 15;21(14):4224-7. doi: 10.1016/j.bmcl.2011.05.074. Epub 2011 May 30.

引用本文的文献

1
Exploring Highly Functionalized Tetrahydropyridine as a Dual Inhibitor of Monoamine Oxidase A and B: Synthesis, Structural Analysis, Single Crystal XRD, Supramolecular Assembly Exploration by Hirshfeld Surface Analysis, and Computational Studies.探索高官能化四氢吡啶作为单胺氧化酶A和B的双重抑制剂:合成、结构分析、单晶X射线衍射、通过 Hirshfeld 表面分析探索超分子组装以及计算研究。
ACS Omega. 2022 Aug 11;7(33):29452-29464. doi: 10.1021/acsomega.2c03909. eCollection 2022 Aug 23.
2
Monoamine Oxidase (MAO) as a Potential Target for Anticancer Drug Design and Development.单胺氧化酶(MAO)作为抗癌药物设计与开发的潜在靶点。
Molecules. 2021 Oct 4;26(19):6019. doi: 10.3390/molecules26196019.
3
Design, synthesis, and evaluation of 3,7-substituted coumarin derivatives as multifunctional Alzheimer's disease agents.
设计、合成及 3,7-取代香豆素衍生物作为多功能阿尔茨海默病药物的评估。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):1607-1621. doi: 10.1080/14756366.2021.1913137.
4
Chromone and donepezil hybrids as new multipotent cholinesterase and monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease.色酮与多奈哌齐杂合物作为新型多效胆碱酯酶和单胺氧化酶抑制剂用于阿尔茨海默病的潜在治疗
RSC Med Chem. 2020 Jan 7;11(2):225-233. doi: 10.1039/c9md00441f. eCollection 2020 Feb 1.
5
Study of peptide fingerprints of parasite proteins and drug-DNA interactions with Markov-Mean-Energy invariants of biopolymer molecular-dynamic lattice networks.利用生物聚合物分子动力学晶格网络的马尔可夫平均能量不变量研究寄生虫蛋白质的肽指纹图谱及药物与DNA的相互作用。
Polymer (Guildf). 2009 Jul 17;50(15):3857-3870. doi: 10.1016/j.polymer.2009.05.055. Epub 2009 Jun 3.
6
Novel C7-Substituted Coumarins as Selective Monoamine Oxidase Inhibitors: Discovery, Synthesis and Theoretical Simulation.新型 C7-取代香豆素类单胺氧化酶抑制剂的发现、合成与理论模拟。
Molecules. 2019 Nov 5;24(21):4003. doi: 10.3390/molecules24214003.
7
Synthesis and evaluation of small molecules bearing a benzyloxy substituent as novel and potent monoamine oxidase inhibitors.作为新型强效单胺氧化酶抑制剂的含苄氧基取代基小分子的合成与评价
Medchemcomm. 2017 Jan 5;8(2):471-478. doi: 10.1039/c6md00586a. eCollection 2017 Feb 1.
8
Coumarin: A Natural, Privileged and Versatile Scaffold for Bioactive Compounds.香豆素:生物活性化合物的天然、有效和多功能支架。
Molecules. 2018 Jan 27;23(2):250. doi: 10.3390/molecules23020250.
9
Thiopurine Drugs Repositioned as Tyrosinase Inhibitors.硫唑嘌呤类药物被重新定位为酪氨酸酶抑制剂。
Int J Mol Sci. 2017 Dec 28;19(1):77. doi: 10.3390/ijms19010077.
10
Computer-aided Drug Design Applied to Parkinson Targets.计算机辅助药物设计在帕金森靶点中的应用。
Curr Neuropharmacol. 2018;16(6):865-880. doi: 10.2174/1570159X15666171128145423.